Nayan Therapeutics
Medfield, US · Founded 2018 · Delaware corporation
Founders & leadership
MD
Milind DeshpandeNamed on SEC filing
JR
Joshua ResnickNamed on SEC filing
RM
Robert MillmanNamed on SEC filing
DN
David NeafusNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$3M disclosed across 1 round · 2019
▶$3MraisedFeb 2019 · 3 investors · BiotechnologyRule 506(b)
▶$3MraisedFeb 2019 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Milind DeshpandeExecutive Officer, Director
- Joshua ResnickDirector
- Robert MillmanDirector, Promoter
- David NeafusExecutive Officer
- Offering amount
- $25M
- Amount sold
- $3M
- Minimum investment
- $381.5K
- Proceeds to insiders
- $25K
- First sale
- Feb 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Nayan Therapeutics raised?
- Nayan Therapeutics has disclosed $3M raised across 1 round.
- Where is Nayan Therapeutics headquartered?
- Nayan Therapeutics is headquartered in Medfield, US.